4.4 Article

Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Advances in autoimmune myasthenia gravis management

Shuhui Wang et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)

Review Clinical Neurology

Advances in autoimmune myasthenia gravis management

Shuhui Wang et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)

Article Clinical Neurology

Gender differences in prednisone adverse effects Survey result from the MG registry

Ikjae Lee et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)

Article Medicine, General & Internal

Randomized Trial of Thymectomy in Myasthenia Gravis

G. I. Wolfe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Clinical Neurology

Impact of multiple sclerosis relapse: The NARCOMS participant perspective

Molly Nickerson et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)

Article Medicine, General & Internal

Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes

S. Berrih-Aknin et al.

REVUE DE MEDECINE INTERNE (2014)

Article Clinical Neurology

Performance of individual items of the quantitative myasthenia gravis score

T. Carolina Barnett et al.

NEUROMUSCULAR DISORDERS (2013)

Article Clinical Neurology

COST ANALYSIS OF MYASTHENIA GRAVIS FROM A LARGE U.S. INSURANCE DATABASE

Jeffrey T. Guptill et al.

MUSCLE & NERVE (2011)

Article Clinical Neurology

MG-ADL: STILL A RELEVANT OUTCOME MEASURE

Srikanth Muppidi et al.

MUSCLE & NERVE (2011)

Article Clinical Neurology

The MG Composite A valid and reliable outcome measure for myasthenia gravis

Ted M. Burns et al.

NEUROLOGY (2010)

Article Clinical Neurology

Disease-specific measure of quality of life for myasthenia gravis

Larry L. Mullins et al.

MUSCLE & NERVE (2008)

Article Clinical Neurology

Validation of the NARCOMS registry: diagnosis

R. A. Marrie et al.

MULTIPLE SCLEROSIS (2007)